Literature DB >> 31945287

[Policy developments of health technology assessment in the European Union].

Aleksandra Baran-Kooiker1, Marcin Czech2, Malwina Hołownia-Voloskova3.   

Abstract

The purpose of the note below is to familiarize readers with the current status and future initiatives of cooperation in the field of health technology assessment (HTA) in the European Union (EU). The European Commission is trying to create a framework for efficient collaboration between member states of EU in the field of HTA and is gradually working on strengthening it. The following initiatives, projects and programs have already been implemented: - Project on Coordination and Development of Health Care Technology Assessment in Europe - The European Collaboration for Assessment of Health Interventions and Technology - European Network for Health Technology Assessment - Beneluxa Initiative, The Valletta Declaration, FINOSE and Fair and Affordable Pricing - European Network for Health Technology Assessment Currently there is an ongoing proposal for an HTA Regulation of the European Parliament and the Council, which is the measurable result of this cooperation. A key element of the proposed regulation is a centralized joint clinical assessment (for HTA purposes) of the efficacy of the medicinal product/medical device.

Year:  2019        PMID: 31945287     DOI: 10.18388/pb.2019_285

Source DB:  PubMed          Journal:  Postepy Biochem        ISSN: 0032-5422


  1 in total

1.  Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries.

Authors:  Sandor Kovács; Zoltán Kaló; Rita Daubner-Bendes; Katarzyna Kolasa; Rok Hren; Tomas Tesar; Vivian Reckers-Droog; Werner Brouwer; Carlo Federici; Mike Drummond; Antal Tamás Zemplényi
Journal:  Health Econ       Date:  2022-03-23       Impact factor: 2.395

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.